Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Lung Cancer

Free Subscription Articles published in Ann Thorac Surg Retrieve available abstracts of 93 articles: HTML format

Single Articles

June 2025
1. XIE S, Hu Q, Wu Z, Wang B, et al
   Clinical and Genetic Characteristics of Early-Onset Lung Adenocarcinoma in a Large Chinese Cohort.
   Ann Thorac Surg. 2025;119:1196-1204.
   PubMed     Abstract available
   
   
   May 2025
2. WU VS, Boutros C, Bassiri A, Jiang B, et al
   Reassessing Efficacy: Understanding Failures in Lung Cancer Screening Despite Low-Dose CT Protocol Adherence.
   Ann Thorac Surg. 2025 May 28:S0003-4975(25)00448.
   PubMed     Abstract available
   
   
   
3. LIANG H, Wang W, Zhang M, Wang R, et al
   Safety and Feasibility of Novel Single-Port Robotic-Assisted Lobectomy/Segmentectomy for Lung Cancer.
   Ann Thorac Surg. 2025 May 15:S0003-4975(25)00420.
   PubMed     Abstract available
   
   
   
4. KALTMAN M, Yalamanchili S, Park JA, Weyant MJ, et al
   High catchment areas for lung cancer screening-eligible patients.
   Ann Thorac Surg. 2025 May 13:S0003-4975(25)00414.
   PubMed     Abstract available
   
   
   
5. DING H, Tao B, Xu L, Jiang G, et al
   Neoadjuvant Immunochemotherapy for Stage II-IIIB Non-Small Cell Lung Cancer with Mutations Beyond EGFR 19del, L858R, and ALK rearrangement.
   Ann Thorac Surg. 2025 May 6:S0003-4975(25)00378.
   PubMed     Abstract available
   
   
   
6. KHAN AA, Shah SK, Naeem W, Ansari M, et al
   Association Between Social Vulnerability Index and Time-to-Treatment in Resectable Non-Small Cell Lung Cancer.
   Ann Thorac Surg. 2025 May 6:S0003-4975(25)00380.
   PubMed     Abstract available
   
   
   
7. LAM GT
   Medicaid Expansion and Regionalization of Lung Cancer Surgery: A Double-Edged Sword?
   Ann Thorac Surg. 2025 May 2:S0003-4975(25)00374.
   PubMed    
   
   
   
8. WOODARD GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, et al
   Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation.
   Ann Thorac Surg. 2025;119:1071-1081.
   PubMed     Abstract available
   
   
   April 2025
9. HOODA Z, Duan Z, Ries S, Antonoff MB, et al
   Association of Medicaid Expansion With Timely Treatment and Access to High-Volume Hospitals in Early-Stage Lung Cancer Patients.
   Ann Thorac Surg. 2025 Apr 11:S0003-4975(25)00321.
   PubMed     Abstract available
   
   
   
10. CHEN J, Zhao ZR, Deng H, Yang C, et al
    Extended sleeve lobectomy after neoadjuvant immunochemotherapy for centrally located non-small cell lung cancer.
    Ann Thorac Surg. 2025 Apr 9:S0003-4975(25)00298.
    PubMed     Abstract available
    
    
    
11. VANWINKLE CK, Fu W, Hassett KP, Thompson MP, et al
    The Association between Participation in a Quality Collaborative and Value in Lung Cancer Surgery.
    Ann Thorac Surg. 2025 Apr 5:S0003-4975(25)00295.
    PubMed     Abstract available
    
    
    
12. RUSCH VW
    An unresolved surgical conundrum: How to manage unsuspected nodal involvement in early-stage lung cancer.
    Ann Thorac Surg. 2025 Apr 2:S0003-4975(25)00282.
    PubMed    
    
    
    March 2025
13. SHAH SK, Khan AA, Basu S, Seder CW, et al
    Minimally Invasive Pneumonectomy vs Open Pneumonectomy: Outcomes and Predictors of Conversion.
    Ann Thorac Surg. 2025;119:634-642.
    PubMed     Abstract available
    
    
    
14. EISENBERG M, Deboever N, Hofstetter WL, Mehran RJ, et al
    Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?
    Ann Thorac Surg. 2025;119:616-624.
    PubMed     Abstract available
    
    
    February 2025
15. VERGE R, Rouch A, Rabinel P, Renaud C, et al
    Evaluation of uncertain resection for localized non-small cell lung cancer: the crucial prognosis of suboptimal lymph node assessment.
    Ann Thorac Surg. 2025 Feb 27:S0003-4975(25)00170.
    PubMed     Abstract available
    
    
    
16. FARINA JM, D'Cunha J
    Sorting Out the Pieces of Fragmented Lung Cancer Care.
    Ann Thorac Surg. 2025 Feb 19:S0003-4975(25)00120.
    PubMed    
    
    
    
17. CROSINA J, Wright F, Irish J, Rashid M, et al
    Long-Term Impact of Regionalization of Thoracic Oncology Surgery.
    Ann Thorac Surg. 2025;119:460-469.
    PubMed     Abstract available
    
    
    
18. RESIO BJ, Tan KS, Skovgard M, Dycoco J, et al
    Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection.
    Ann Thorac Surg. 2025;119:308-315.
    PubMed     Abstract available
    
    
    
19. HUANG L, Petersen RH
    Impact of Margin Distance on Locoregional Recurrence and Survival After Thoracoscopic Segmentectomy.
    Ann Thorac Surg. 2025;119:316-324.
    PubMed     Abstract available
    
    
    
20. HAYANGA JWA, Luo X, Hasasna I, Rothenberg P, et al
    Intersection of Race, Rurality, and Income in Defining Access to Minimally Invasive Lung Surgery.
    Ann Thorac Surg. 2025;119:325-332.
    PubMed     Abstract available
    
    
    January 2025
21. POTTER AL, Guo Q, Srinivasan D, Yang ME, et al
    Assessing Lung Cancer Screening Eligibility of Lung Cancer Patients in the Boston Lung Cancer Study: An Analysis of 7,186 Lung Cancer Cases.
    Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00067.
    PubMed     Abstract available
    
    
    
22. ANTONOFF MB, Mitchell KG, Kim SS, Salfity HV, et al
    The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer.
    Ann Thorac Surg. 2025 Jan 9:S0003-4975(24)00960.
    PubMed     Abstract available
    
    
    
23. KRANTZ SB, Mitzman B, Antonoff MB, Backhus L, et al
    Thoracic Surgery Outcomes Research Network (ThORN) Consensus Document on Defining a High Quality Wedge Resection for Early Stage Lung Cancer.
    Ann Thorac Surg. 2025 Jan 8:S0003-4975(25)00004.
    PubMed     Abstract available
    
    
    
24. MIMAE T, Miyata Y, Tsubokawa N, Kudo Y, et al
    Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.
    Ann Thorac Surg. 2025;119:192-198.
    PubMed     Abstract available
    
    
    December 2024
25. STUART CM, Mott NM, Bronsert MR, Randhawa SK, et al
    The Association between Sociodemographic Factors and Delays to Minimally Invasive Surgery for Stage IA-IIIA Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Dec 24:S0003-4975(24)01115.
    PubMed     Abstract available
    
    
    
26. MATSUDO K, Takada K, Kinoshita F, Hashinokuchi A, et al
    CD155 Expression in Early-Stage Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:1197-1205.
    PubMed     Abstract available
    
    
    November 2024
27. HOODA Z, Antonoff MB
    Using Lung Cancer Screening To Treat the Whole Patient, Not the Disease.
    Ann Thorac Surg. 2024 Nov 27:S0003-4975(24)01017.
    PubMed    
    
    
    
28. AL-THANI S, Nasar A, Villena-Vargas J, Chow O, et al
    Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer
    Ann Thorac Surg. 2024 Nov 13:S0003-4975(24)00957.
    PubMed     Abstract available
    
    
    
29. ODEH A, Verm R, Park S, Swanson J, et al
    Fragmented care, Commission on Cancer Accreditation and Overall Survival in Patients Receiving Surgery and Chemotherapy for Lung Cancer.
    Ann Thorac Surg. 2024 Nov 11:S0003-4975(24)00940.
    PubMed     Abstract available
    
    
    
30. LANUTI M
    What Is Best Liquid Remnant for Resected Early-Stage Non-small Cell Lung Cancer?
    Ann Thorac Surg. 2024;118:1144-1145.
    PubMed    
    
    
    October 2024
31. ELY S, Osarogiagbon RU
    Metrics for Benchmarking Lung Cancer Surgery Quality: Not waiting for Godot!
    Ann Thorac Surg. 2024 Oct 29:S0003-4975(24)00924.
    PubMed    
    
    
    
32. HOODA Z, Antonoff MB
    Less is More-Further Evidence Favoring Segmentectomy for Clinical Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00882.
    PubMed    
    
    
    
33. LI Z, Wu L, Wang C, Wang S, et al
    Outcomes after neoadjuvant therapy with/without immunotherapy followed by pneumonectomy in non-small cell lung cancer patients.
    Ann Thorac Surg. 2024 Oct 25:S0003-4975(24)00879.
    PubMed     Abstract available
    
    
    
34. D'ANDRILLI A, Marinucci BT, Ciccone AM, Ibrahim M, et al
    CARINAL RECONSTRUCTION FOR LUNG CANCER AND AIRWAY TUMORS: LONG-TERM RESULTS.
    Ann Thorac Surg. 2024 Oct 22:S0003-4975(24)00876.
    PubMed     Abstract available
    
    
    
35. LI X, Li Q, Yang F, Gao E, et al
    Survival Outcomes of Neoadjuvant Therapy Followed by Sleeve Lobectomy in Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 17:S0003-4975(24)00863.
    PubMed     Abstract available
    
    
    
36. KIM SS, Cooke DT, Kidane B, Tapias LF, et al
    The Society of Thoracic Surgeons Expert Consensus on the Multidisciplinary Management and Resectability of Locally Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00861.
    PubMed     Abstract available
    
    
    
37. RUSCH VW
    Sublobar Resection for Subsolid Lung Adenocarcinomas: How Much Margin Is Enough?
    Ann Thorac Surg. 2024;118:810.
    PubMed    
    
    
    
38. GROTH SS
    Unraveling the Association Between Size of Lepidic-Predominant Adenocarcinomas and the Risk of Nodal Metastasis.
    Ann Thorac Surg. 2024;118:823-824.
    PubMed    
    
    
    
39. KAMTAM DN, Berry MF, Lui NS, Satoyoshi M, et al
    What Is an Adequate Margin During Sublobar Resection of
    Ann Thorac Surg. 2024;118:801-809.
    PubMed     Abstract available
    
    
    
40. SI H, Xu L, Zhao Y, Su H, et al
    Spread Through Air Spaces in Residual Tumor Classification for Clinical IA Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;118:825-833.
    PubMed     Abstract available
    
    
    
41. WONG LY, Elliott IA, Liou DZ, Backhus LM, et al
    Lepidic-Type Lung Adenocarcinomas: Is It Safe to Observe for Growth Before Treating?
    Ann Thorac Surg. 2024;118:817-823.
    PubMed     Abstract available
    
    
    September 2024
42. XU R, Miao P
    Public health and social work collaborative rehabilitation assessment of different lung cancer resection.
    Ann Thorac Surg. 2024 Sep 20:S0003-4975(24)00825.
    PubMed    
    
    
    
43. BROWNLEE AR
    When a Lung Nodule Program Becomes Self-Aware.
    Ann Thorac Surg. 2024;118:718-719.
    PubMed    
    
    
    
44. KRANTZ SB, Su KW
    More for More's Sake Alone? Completion Lobectomy in the Setting of Occult Nodal Disease.
    Ann Thorac Surg. 2024;118:663-664.
    PubMed    
    
    
    
45. HEADRICK JR JR, Parker MJ, Miller AD
    Artificial Intelligence: Can It Save Lives, Hospitals, and Lung Screening?
    Ann Thorac Surg. 2024;118:712-718.
    PubMed     Abstract available
    
    
    
46. KNEUERTZ PJ
    Real-World Experience Favors a Neoadjuvant Strategy of Chemoimmunotherapy for Locoregionally Advanced NSCLC.
    Ann Thorac Surg. 2024;118:681-682.
    PubMed    
    
    
    
47. MARTIN JL, Mack SJ, Rshaidat H, Collins ML, et al
    Wedge Resection Outcomes: A Comparison of Video-Assisted and Robot-Assisted Wedge Resections.
    Ann Thorac Surg. 2024;118:683-690.
    PubMed     Abstract available
    
    
    August 2024
48. BROWN LM, Bonnell L, Parsons N, Cooke DT, et al
    Predictors of Discharge with Supplemental Oxygen after Lobectomy for Lung Cancer.
    Ann Thorac Surg. 2024 Aug 28:S0003-4975(24)00693.
    PubMed     Abstract available
    
    
    
49. MCALLISTER MA, Herrera-Zamora J, Barcelos RR, Leo R, et al
    Left Upper Lobectomy versus Trisegmentectomy for Lung Cancer: A Propensity-Score Matched Comparison.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00684.
    PubMed     Abstract available
    
    
    
50. TONG BC, Bonnell LN, Habib RH, Shahian DM, et al
    The STS 2024 Risk Models for Lung Cancer Resection: Continued Refinement and Improved Outcomes.
    Ann Thorac Surg. 2024 Aug 26:S0003-4975(24)00686.
    PubMed     Abstract available
    
    
    
51. ROSSETTI NE, Eaton DB Jr, Tohmasi S, Heiden BT, et al
    Early-stage lung cancer in the era of lung cancer screening: VA outperforms other insurance models.
    Ann Thorac Surg. 2024 Aug 21:S0003-4975(24)00678.
    PubMed     Abstract available
    
    
    
52. MITZMAN B
    The Entire NSCLC Spectrum: No Cancer Left Behind.
    Ann Thorac Surg. 2024;118:393-394.
    PubMed    
    
    
    
53. DAI J, Sun F, Bao M, Cao J, et al
    Pulmonary Function Recovery and Displacement Patterns After Anatomic Segmentectomy vs Lobectomy.
    Ann Thorac Surg. 2024;118:365-374.
    PubMed     Abstract available
    
    
    
54. CAMPISI A, Dell'Amore A, Faccioli E, Fang W, et al
    A Multicenter Retrospective Case-Control Study on Simple vs Extended Sleeve Lobectomies.
    Ann Thorac Surg. 2024;118:375-383.
    PubMed     Abstract available
    
    
    
55. WAN S, Shen Z, Hu S, Zhang L, et al
    Spread Through Air Spaces in Stage I Pulmonary Large Cell Neuroendocrine Carcinoma.
    Ann Thorac Surg. 2024;118:385-393.
    PubMed     Abstract available
    
    
    July 2024
56. RUSCH VW
    Surgical Resection for Pleural Mesothelioma: Is It All About Patient Selection?
    Ann Thorac Surg. 2024;118:223-224.
    PubMed    
    
    
    
57. NAKAMURA A, Hashimoto M, Kuroda A, Matsumoto S, et al
    Impact of Operation on Disease Progression and Survival of Patients With Pleural Mesothelioma.
    Ann Thorac Surg. 2024;118:216-223.
    PubMed     Abstract available
    
    
    
58. KAGIMOTO A, Ishida M, Mimura T
    Significance of the Goddard Score in Predicting Complications Related to Air Leak After Lobectomy.
    Ann Thorac Surg. 2024;118:233-239.
    PubMed     Abstract available
    
    
    June 2024
59. WONG LY, Dale R, Kapula N, Elliott IA, et al
    Impacts of Positive Margins and Surgical Extent on Outcomes after Early-Stage Lung Cancer Resection.
    Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00460.
    PubMed     Abstract available
    
    
    
60. NOBEL TB, Tan KS, Adusumilli PS, Bains MS, et al
    Outcomes of Patients Undergoing Segmentectomy for Occult Node-Positive Clinical Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Jun 10:S0003-4975(24)00448.
    PubMed     Abstract available
    
    
    
61. BRIBRIESCO A
    Aim Local, Expect Global-EGFR and Recurrence in Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1119-1120.
    PubMed    
    
    
    
62. YANG F, Sun K, Li F, Li X, et al
    The Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Clinical Stage I Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:1111-1119.
    PubMed     Abstract available
    
    
    May 2024
63. BOU-SAMRA P, Kennedy GT, Chang A, Guo E, et al
    Phase 2 Trial of VGT-309: Cathepsin-Based Near-Infrared Probe for Intraoperative Molecular Imaging.
    Ann Thorac Surg. 2024 May 30:S0003-4975(24)00396.
    PubMed     Abstract available
    
    
    
64. SAWABATA N, Hamaji M, Yoshikawa D, Miyata R, et al
    Clustered circulating tumor cells as a predictor of adjuvant-chemotherapy efficacy in lung cancer.
    Ann Thorac Surg. 2024 May 22:S0003-4975(24)00379.
    PubMed     Abstract available
    
    
    
65. RUSCH VW
    Wedge Resection Versus Segmentectomy for Clinical Stage IA Non-small Cell Lung Cancer: Are They Truly Oncologically Equivalent?
    Ann Thorac Surg. 2024 May 9:S0003-4975(24)00359.
    PubMed    
    
    
    April 2024
66. TAKAHASHI T
    Study-design of adjuvant chemotherapy for lung cancer: A cart before the horse.
    Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00285.
    PubMed    
    
    
    
67. SHAHZAD MH, Spicer JD, Rusch VW, Kneuertz PJ, et al
    Perioperative Immunotherapy for Node-Negative Non-Small Cell Lung Cancer - Current Evidence and Future Directions.
    Ann Thorac Surg. 2024 Apr 13:S0003-4975(24)00280.
    PubMed     Abstract available
    
    
    
68. BLASBERG JD, Li A
    Evening the Odds: Making 1 + 1 = 2 for Bilobectomy.
    Ann Thorac Surg. 2024;117:874-875.
    PubMed    
    
    
    
69. KAMIGAICHI A, Mimae T, Tsubokawa N, Miyata Y, et al
    Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma.
    Ann Thorac Surg. 2024;117:743-751.
    PubMed     Abstract available
    
    
    March 2024
70. TOWE CW, Grau-Sepulveda MV, Hartwig MG, Kang L, et al
    STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00191.
    PubMed     Abstract available
    
    
    
71. FERRARIS VA
    Venous Thromboembolism as Postoperative Complication Following Lung Cancer Operations.
    Ann Thorac Surg. 2024 Mar 15:S0003-4975(24)00188.
    PubMed    
    
    
    
72. STILES BM, Rodriguez-Quintero JH
    A "Solid" Rationale for Lymphadenectomy in Small, Peripheral Lung Cancers.
    Ann Thorac Surg. 2024;117:593.
    PubMed    
    
    
    February 2024
73. ALDERETE IS, Nakata K, Hartwig MG
    Overcoming Hesitancy: Embracing Extended Sleeve Lobectomy for Advanced Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00120.
    PubMed    
    
    
    
74. PONTULA A, Spies CS, Hartwig MG
    Incidentally Found Lung Cancer Following Lung Transplantation: Apples and Oranges.
    Ann Thorac Surg. 2024 Feb 16:S0003-4975(24)00118.
    PubMed    
    
    
    
75. DUNNE EG, Fick CN, Isbell JM, Chaft JE, et al
    The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Feb 3:S0003-4975(24)00080.
    PubMed     Abstract available
    
    
    
76. YOUNG AM, Viktorsson SA, Strobel RJ, Rotar EP, et al
    Five-Year Sustained Impact of a Thoracic Enhanced Recovery After Surgery Program.
    Ann Thorac Surg. 2024;117:422-430.
    PubMed     Abstract available
    
    
    
77. FERRARI-LIGHT D, Kneuertz PJ
    Life in the Fast Lane: Rapid Discharge After Minimally Invasive Anatomic Lung Resection Is Feasible and Safe.
    Ann Thorac Surg. 2024;117:303-304.
    PubMed    
    
    
    January 2024
78. COSTER JN, Sanchez PG
    Surviving Incidentally Found Non-Small Cell Lung Cancer After Lung Transplantation.
    Ann Thorac Surg. 2024 Jan 27:S0003-4975(24)00071.
    PubMed    
    
    
    
79. FONG AJ, Reich H, Mirocha J, Wong A, et al
    Disparities and Underutilization of Surgery for Early Stage Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Jan 26:S0003-4975(24)00067.
    PubMed     Abstract available
    
    
    
80. AXTELL AL, Gaissert HA, Bao X, Auchincloss HG, et al
    Predictors of Venous Thromboembolism after Lung Cancer Resection.
    Ann Thorac Surg. 2024 Jan 25:S0003-4975(24)00014.
    PubMed     Abstract available
    
    
    
81. MARTINS RS, Razi SS, Alnajar A, Poulikidis K, et al
    Neoadjuvant versus Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2024 Jan 19:S0003-4975(24)00013.
    PubMed     Abstract available
    
    
    
82. POTTER AL, Senthil P, Keshwani A, McCleery S, et al
    Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
    Ann Thorac Surg. 2024 Jan 10:S0003-4975(24)00004.
    PubMed     Abstract available
    
    
    
83. MIMAE T, Miyata Y, Tsubokawa N, Shimada Y, et al
    Sublobar resection in early non-small cell lung cancer with epidermal growth factor receptor mutant.
    Ann Thorac Surg. 2024 Jan 8:S0003-4975(24)00002.
    PubMed     Abstract available
    
    
    
84. KNEUERTZ PJ, Ferrari-Light D, Altorki NK
    Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma-Takeaways From Modern Randomized Trials.
    Ann Thorac Surg. 2024 Jan 5:S0003-4975(24)00001.
    PubMed     Abstract available
    
    
    
85. LI AX, Canavan ME, Ermer T, Maduka RC, et al
    Respect the Middle Lobe: Perioperative Risk of Bilobectomy Compared With Lobectomy and Pneumonectomy.
    Ann Thorac Surg. 2024;117:163-171.
    PubMed     Abstract available
    
    
    November 2023
86. COLLINS ML, Mack SJ, Whitehorn GL, Till BM, et al
    Access to Guideline Concordant Care for Node-Positive Non-Small Cell Lung Cancer in the United States.
    Ann Thorac Surg. 2023 Nov 21:S0003-4975(23)01165.
    PubMed     Abstract available
    
    
    
87. YUN T, Zhang Y, Liu A, Qin Y, et al
    Randomized Trial of Modified Chest Tube Placement vs Routine Placement After Lung Resection.
    Ann Thorac Surg. 2023;116:1013-1019.
    PubMed     Abstract available
    
    
    October 2023
88. MORKVED AL, Sogaard M, Skjoth F, Ording AG, et al
    Risk and timing of venous thromboembolism after surgery for lung cancer: a nationwide cohort study.
    Ann Thorac Surg. 2023 Oct 25:S0003-4975(23)01073.
    PubMed     Abstract available
    
    
    
89. RSHAIDAT H, Okusanya OT
    Using the Ultimate Lung Biopsy.
    Ann Thorac Surg. 2023;116:701-702.
    PubMed    
    
    
    September 2023
90. RUSCH VW
    Process improvement in lymphadenectomy for lung cancer: The wave of the future?
    Ann Thorac Surg. 2023 Sep 15:S0003-4975(23)00958.
    PubMed    
    
    
    
91. SPIES CS, Ochoa TN, Pontula A, Harris CS, et al
    With Comparable Outcomes, Should Early Stage Lung Cancer Be A Contraindication to Lung Transplant?
    Ann Thorac Surg. 2023 Sep 11:S0003-4975(23)00934.
    PubMed     Abstract available
    
    
    
92. OSAROGIAGBON RU, Ray MA, Fehnel C, Akinbobola O, et al
    Two Interventions on Pathologic Nodal Staging in a Population-Based Lung Cancer Resection Cohort.
    Ann Thorac Surg. 2023 Sep 5:S0003-4975(23)00927.
    PubMed     Abstract available
    
    
    August 2023
93. POTTER AL, Spasojevic A, Raman V, Hurd JC, et al
    The Increasing Adoption of Minimally Invasive Lobectomy in the United States.
    Ann Thorac Surg. 2023;116:222-229.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.